ArticleBMC psychiatry2026
Associations between serum amino acids and genetic liability to depression in the LURIC cohort.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsBlood concentrations of amino acids have been associated with depression, although findings have been inconsistent. We investigated associations between serum amino acid concentrations and genetic liability to depression, assessed by two genetic depression risk scores, in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
methodsThe LURIC study enrolled 3,316 participants referred for coronary angiography; serum amino acid measurements were available for 2,143 individuals and were quantified by ion-exchange chromatography. Two weighted genetic depression risk scores, based on 101 and 220 genome-wide significant variants, were calculated. Associations between genetic depression risk scores and amino acid concentrations were assessed using multivariable linear regression models adjusted for age, sex, body mass index, renal function (eGFR), diabetes, hypertension, and coronary artery disease. Clinical depression data were not available; thus, analyses reflect genetic liability rather than manifest depression.
resultsIn multivariable-adjusted analyses, higher genetic depression risk (per SD increase) was associated with lower concentrations of α-aminoadipic acid (GDRS₁₀₁: β = -0.097, 95% CI - 0.161 to - 0.033, p = 0.003; GDRS₂₂₀: β = -0.076, 95% CI - 0.141 to - 0.011, p = 0.021), which remained significant after false discovery rate (FDR) correction. α-aminobutyric acid showed inverse associations that did not remain significant after FDR correction. No statistically significant associations for other amino acids remained after multivariable adjustment and correction for multiple testing. Restricted cubic spline analyses suggested predominantly linear relationships, with evidence of non-linearity observed for selected amino acids, particularly homoarginine with respect to GDRS₂₂₀ (p for non-linearity = 0.005).
conclusionGenetic liability to depression was associated with differences in serum amino acid concentrations, particularly lower α-aminoadipic acid concentrations in this cardiovascular cohort, whereas associations with other amino acids were not robust after correction for multiple testing. These findings are associative and hypothesis-generating and should be confirmed in cohorts with detailed depression phenotyping and longitudinal follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.